Should You Buy These Dividend Favourites? GlaxoSmithKline plc, Diageo plc And Aberdeen Asset Management plc

A look at three high-yielding blue chip favourites: GlaxoSmithKline plc (LON:GSK), Diageo plc (LON:DGE) and Aberdeen Asset Management plc (LON:ADN).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

GSK

GlaxoSmithKline (LSE: GSK) has pledged to keep its dividend at 80p per share until 2017, despite declining earnings and rapidly falling dividend cover. Many analysts have recently lowered their estimates for GSK’s earnings in 2015 and 2016, as generic competition for GSK’s blockbuster respiratory drug, Advair, has been much tougher than originally expected.

But there is cause for optimism. GSK has a pipeline of some 40 new drugs that are in late-stage clinical trials, and the recent release of new positive data for three of its next-generation respiratory drugs — Breo, Anoro and Incruse — should help GSK to gain market share and offset declining Advair sales.

Analysts expect GSK’s underlying EPS will decline by 20% in 2015, to 75.9p, which implies its shares trade at a forward P/E of 17.7. But in 2016, earnings are expected to rebound by 11%, to 84.3p. And on that forecast, its forward P/E will fall to a more reasonable 16.0.

Should you invest £1,000 in Phoenix Group Holdings Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Phoenix Group Holdings Plc made the list?

See the 6 stocks

Shares in GSK have a prospective dividend yield of 6.0%.

Diageo

Diageo (LSE: DGE) is seeing growth slow, too. The company reported a 5% increase in net sales for the year ending 30 June, but this was primarily due to its consolidation of United Spirits revenues in its own figures. Organic net sales was actually flat, with Diageo reporting a 1% drop in shipment volumes.

Recent adverse currency movements and slowing emerging market economies are largely to blame, but changing consumer tastes and brand fatigue are also factors. Diageo has been slow in gaining a foothold in the growing bourbon market in North America, where sales of Diageo’s Johnnie Walker scotch, Smirnoff vodka and Captain Morgan rum have been making double digit declines.

On the upside, productivity gains and price increases have led to an expansion of operating margins. Its organic operating margin increased 24 basis points in the year and now stands at 28.35%. This demonstrates the company’s competitive advantage and its wide economic moat.

Shares in Diageo are expensive, though, trading at 20.6 times its prospective 2015/6 earnings, against an average forward P/E of 15.4 for the FTSE 100. Its prospective dividend yield is also not the most attractive, at 3.3%, but at least it is still growing.

Aberdeen Asset Management

Aberdeen Asset Management (LSE: ADN) has been hard hit by recent capital outflows from emerging markets. Trading conditions are set to get even worse, as investors will likely want to reduce their exposure to Asia and emerging markets in anticipation of a US interest rate rise.

But times of economic weakness often provide the most rewarding investing opportunities. The lower valuation multiples in emerging markets will, at some point in time, prompt a change in market sentiment.

Aberdeen is expected to see underlying EPS fall 8% this year, to 29.6p. In 2016, underlying EPS is predicted to fall another 12%, to 26.2p. As a result, its shares trade at forward P/E ratios of 11.6 and 13.6 times their respective 2015 and 2016 earnings.

Although earnings are set to trend downwards, Aberdeen will still be able to maintain its progressive dividend policy. Even as analysts expect Aberdeen will increase its dividend by 6% this year, its dividend cover is expected to fall to just 1.7x. Its shares have a prospective dividend yield of 5.6%.

Like buying £1 for 31p

This seems ridiculous, but we almost never see shares looking this cheap. Yet this Share Advisor pick has a price/book ratio of 0.31. In plain English, this means that investors effectively get in on a business that holds £1 of assets for every 31p they invest!

Of course, this is the stock market where money is always at risk — these valuations can change and there are no guarantees. But some risks are a LOT more interesting than others, and at The Motley Fool we believe this company is amongst them.

What’s more, it currently boasts a stellar dividend yield of around 10%, and right now it’s possible for investors to jump aboard at near-historic lows. Want to get the name for yourself?

See the full investment case

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jack Tang has no position in any shares mentioned. The Motley Fool UK has recommended Aberdeen Asset Management and GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

We think earning passive income has never been easier

Do you like the idea of dividend income?

The prospect of investing in a company just once, then sitting back and watching as it potentially pays a dividend out over and over?

If you’re excited by the thought of regular passive income payments, as well as the potential for significant growth on your initial investment…

Then we think you’ll want to see this report inside Motley Fool Share Advisor — ‘5 Essential Stocks For Passive Income Seekers’.

What’s more, today we’re giving away one of these stock picks, absolutely free!

Get your free passive income stock pick

More on Investing Articles

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

£10,000 invested in Tesco shares just a fortnight ago is already worth…

Tesco shares went through a sharp wobble a couple of weeks ago, but here's a look at what's happened to…

Read more »

Young female analyst working at her desk in the office
Investing Articles

9.6% yield! Here’s the dividend forecast for Glencore shares to 2027!

At nearly 10%, Glencore shares have one of the largest dividend yields on the FTSE 100. Here's why they could…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

£20,000 Stocks and Shares ISA: how long would it take to reach £1 million?

This writer considers how long it would take an investor to reach a seven-figure sum by maxing out their Stocks…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

UK bonds: a once-in-a-decade passive income opportunity?

Gilts are offering some very attractive yields at the moment. But Stephen Wright thinks passive income investors could still do…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Investing Articles

Down 99%, this stock has been crushed by AI and is now a penny share!

Chegg has gone from being a fast-growth tech stock to a penny share trading for less than $1 in the…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

Could this rapidly growing coffee stock be the next Warren Buffett-style winner?

Discover why a fast-growing US coffee chain could be the next big US growth stock, with similarities to stocks picked…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

2 high-yielding dividend stocks I continue to double down on

Andrew Mackie explores two FTSE 350 high-yielding dividend stocks he's been snapping up in the last few weeks for his…

Read more »

Stack of British pound coins falling on list of share prices
Investing Articles

Why did the AstraZeneca share price just fall, and what should we do?

The AstraZeneca share price just took a hit as President Trump announced a price war against the US pharmaceutical industry.

Read more »